Considering the increasing number of biopharmaceutical companies pursuing more virtual and digital tools, the need for world class digital protection is a pressing challenge. In Vivo talks to two cyber security experts about best practice when securing data assets.

Supply chain expert outlines to In Vivo how pharma can create resilient and secure supply chains and some benefits of localization.

As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation. 

A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.